These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10765029)

  • 1. Lack of in vitro and in vivo selection of bacterial resistance by roxithromycin.
    Drago L; Fassina MC; De Vecchi E; Mombelli B; Lombardi A; Gismondo MR
    Chemotherapy; 2000; 46(3):160-5. PubMed ID: 10765029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roxithromycin as a possible agent for prophylaxis of endocarditis: a study in normal volunteers.
    Smith GE; Fulford MR; Matthews RW; Speller DC
    J Antimicrob Chemother; 1989 Mar; 23(3):417-25. PubMed ID: 2732123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
    Sakran W; Raz R; Chazan B; Koren A; Colodner R
    Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility to roxithromycin of gram-positive cocci isolated from patients with lowered immunity].
    Mróz E; Podolak-Dawidziak M; Grzybek-Hryncewicz K; Dworniczek E
    Med Dosw Mikrobiol; 1994; 46(1-2):5-8. PubMed ID: 7967928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of roxithromycin against respiratory pathogens.
    Facinelli B; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():33-5. PubMed ID: 12041781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
    Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
    Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
    Yasuda Y; Kasahara K; Mizuno F; Nishi K; Mikasa K; Kita E
    Antimicrob Agents Chemother; 2007 May; 51(5):1741-52. PubMed ID: 17353244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roxithromycin: review of its antimicrobial activity.
    Bryskier A
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():1-21. PubMed ID: 9579708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New pharmacological approaches of macrolides. Example of roxithromycin].
    Bergogne-Bérézin E
    Presse Med; 1997 Mar; 26 Suppl 2():4-10. PubMed ID: 9113046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of 941 beta haemolytic streptococci to antibacterial drugs.
    Faoagali JL; Jackson SE; Rose GR
    N Z Med J; 1976 Sep; 84(571):183-6. PubMed ID: 1070586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of subinhibitory concentrations of norfloxacin, erythromycin and roxithromycin on Pseudomonas aeruginosa virulence factors].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):115-7. PubMed ID: 7489133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of roxithromycin on adhesion of Klebsiella pneumoniae strains 3051, CF504 and LM21.
    Favre-Bonté S; Forestier C; Joly B
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():51-5. PubMed ID: 9579713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z; Rosenberg S; Dan M
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of pharmacokinetic interaction of paroxetine and roxithromycin on bencycloquidium bromide in healthy subjects.
    Agbokponto JE; Luo Z; Liu R; Liu Z; Liang M; Ding L
    Eur J Pharm Sci; 2015 Mar; 69():37-43. PubMed ID: 25559065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo activity of roxithromycin against Chlamydia trachomatis.
    Furneri PM; Sardo S; Cianci A; Palumbo G; Tempera G
    J Chemother; 1991 Jan; 3 Suppl 1():36-8. PubMed ID: 12041782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.